|
End-of-day quote
NYSE
|
||
| - USD | - |
|
| 06/16/06 | Allergan : Obama's inversion curbs kill Pfizer's $160 billion Allergan deal | RE |
| 31/16/31 | Argus Media close to stake sale, Temasek among bidders - sources | RE |
| Manager | Title | Age | Since |
|---|---|---|---|
Eric Boyer
IRC | Investor Relations Contact | - | 03/02/2014 |
Carlos Pascual
PRN | Corporate Officer/Principal | - | 12/01/2015 |
| Director | Title | Age | Since |
|---|---|---|---|
Daniel H. Yergin
BRD | Director/Board Member | 79 | 26/11/2013 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.32% | +1.34% | -4.36% | +19.88% | 14TCr | |
| -0.36% | +1.15% | +5.06% | +47.85% | 8.81TCr | |
| +0.93% | -0.25% | -19.84% | -15.66% | 4.7TCr | |
| +1.03% | +2.06% | +13.18% | +26.98% | 4.62TCr | |
| -1.72% | -1.26% | -13.89% | +10.88% | 3.56TCr | |
| -1.58% | +2.32% | -6.64% | -29.36% | 2.22TCr | |
| -0.43% | -0.43% | -10.49% | +1.08% | 2.2TCr | |
| +1.00% | +5.52% | -13.11% | +9.48% | 2.18TCr | |
| +0.42% | +1.19% | +22.92% | +73.61% | 1.72TCr | |
| Average | -0.01% | +0.12% | -3.02% | +16.08% | 5TCr | |
| Weighted average by Cap. | +0.08% | -0.52% | -2.83% | +19.87% |
- Stock Market
- Stocks
- Stock
Select your edition
All financial news and data tailored to specific country editions
